# Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy

Study · id `cardio:ct-nct04246450` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04246450](<https://clinicaltrials.gov/study/NCT04246450>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04246450

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 675 participants.

## Technical summary

Registry record NCT04246450. Non-randomized; no masking; primary purpose prevention. Start 2020-09-01 (actual); primary completion 2025-05-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 675 participants (planned count; ClinicalTrials.gov record NCT04246450, source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)
- Started: 2020-09-01 (actual) (ClinicalTrials.gov record NCT04246450, source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)
- Primary completion: 2025-05-01 (anticipated) (ClinicalTrials.gov record NCT04246450, source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)
- Completion: 2025-05-01 (anticipated) (ClinicalTrials.gov record NCT04246450, source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)
- Countries: Greece (ClinicalTrials.gov record NCT04246450, source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04246450-2021-04-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy
- Acronym: ReCONSIDER
- Condition: Sudden Cardiac Death Due to Cardiac Arrhythmia
- Condition: Dilated Cardiomyopathy
- Intervention (Device): Implantable Cardioverter Defibrillator (ICD) insertion
- Lead sponsor: University of Athens
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Dilated cardiomyopathy (`cardio:dilated-cardiomyopathy`)

## Provenance

Content hash: 9834f12d97adb4a84f1964a86cbe8b19f8dfee61fb0900ffd64eefd3dc4ef34d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
